<DOC>
	<DOCNO>NCT02068846</DOCNO>
	<brief_summary>The purpose study analyze BK viral infection salivary gland disease ; specifically , determine definitive relationship BK Virus HIV associate salivary gland disease ( HIVSGD ) . Participants adults HIV+SGD+ randomize 1:1 receive BK Virus antiviral ( ciprofloxacin ) placebo 28 day . Salivary function/protein secretion correlate BK polyomavirus titer . We expect patient HIV+SGD+ elevate oral BK polyomavirus viral load benefit Ciprofloxacin .</brief_summary>
	<brief_title>BK Virus Salivary Gland Disease : Treating Potential Etiologic Agent</brief_title>
	<detailed_description />
	<mesh_term>Salivary Gland Diseases</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>HIV positive Salivary Gland Disease Ability read understand English Allergy family fluoroquinolones ( include ciprofloxacin ) Currently take tizanidine Concurrently take antiacid contain magnesium hydroxide aluminum hydroxide Current use Theophylline Previous tendon disorder Rheumatoid arthritis History seizures Current use phenytoin Current use glyburide Current use methotrexate Severe renal impairment ( know creatinine clearance &lt; 30 dialysis )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>Salivary Gland Disease</keyword>
	<keyword>Benign Lymphoepithelial Lesion</keyword>
	<keyword>BK Polyomavirus</keyword>
</DOC>